On the contrary, when considering the HCV+ patients exclusively, we observed that the presence of HCC significantly reduced PCSK9 levels (277.1 ± 126.1 vs. 357.6 ± 110.1; p < 0.001) (Figure 1C). Here, PCSK9 is linked to hepatocellular carcinoma.